Inventor
KHATTAR DHIRAJ
IN13 patents
⚠️ This page may combine multiple inventors who share the name “KHATTAR DHIRAJ”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FRESENIUS KABI ONCOLOGY LTD
7 patentsUS10525059B2Jan 7, 2020
Pharmaceutical compositions comprising Afatinib
FRESENIUS KABI ONCOLOGY LTD12 citations82
US9968608B2May 15, 2018
Pharmaceutical compositions comprising pemetrexed and tromethamine
FRESENIUS KABI ONCOLOGY LTD3 citations68
US9421207B2Aug 23, 2016
Pharmaceutical compositions comprising pemetrexed and tromethamine
FRESENIUS KABI ONCOLOGY LTD4 citations68
US11883403B2Jan 30, 2024
Pharmaceutical compositions comprising Afatinib
FRESENIUS KABI ONCOLOGY LTD0 citations59
US8927023B2Jan 6, 2015
Biocompatible, non-biodegradable, non-toxic polymer useful for nanoparticle pharmaceutical compositions
FRESENIUS KABI ONCOLOGY LTD1 citations48
US7699987B2Apr 20, 2010
Stabilized formulation
FRESENIUS KABI ONCOLOGY LTD0 citations47
US9669048B2Jun 6, 2017
Stable pharmaceutical composition of 5-aza-2′-deoxycitidine
FRESENIUS KABI ONCOLOGY LTD0 citations44
DABUR RES FOUNDATION
4 patentsUS6322817B1Nov 27, 2001
Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
DABUR RES FOUNDATION103 citations96
US6365191B1Apr 2, 2002
Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
DABUR RES FOUNDATION68 citations93
US6596755B2Jul 22, 2003
Oral formulation of methylglyoxal and its imino acid conjugates for human use
DABUR RES FOUNDATION5 citations62
US6656970B2Dec 2, 2003
Method and compositions for solubilization of pentacyclic triterpenes
DABUR RES FOUNDATION2 citations60